• Clinical Communiqué Volume 5 Issue 1 March 2018

    Clinical Communiqué Volume 5 Issue 1 March 2018

    Welcome to the first edition of the Clinical Communiqué for 2018. Before we look ahead for the year, it is worth recalling the June 2017 Clinical Communique. In that edition, we focussed on the complex issues surrounding the treatment of pain, and the risks associated with prescribing and combining sedative medications.

  • Clinical Communiqué Volume 4 Issue 4 December 2017

    Clinical Communiqué Volume 4 Issue 4 December 2017

    Welcome to the December 2017 edition of the Clinical Communiqué. For the final edition of the year, we have chosen to present a selection of cases that demonstrate some of the important non-clinical aspects of coronial investigations and inquest findings.

  • Clinical Communiqué Volume 5 Issue 2 June 2018

    Clinical Communiqué Volume 5 Issue 2 June 2018

    Welcome to the June 2018 edition of the Clinical Communiqué. In this edition, we present three cases of patients who died shortly after being assessed and discharged from an emergency department. In each case, an evolving abdominal problem was missed, and the symptoms were attributed to other, less critical causes.

  • An article evaluating the effect of the Clinical Communique has been published by the BMJ

    An article evaluating the effect of the Clinical Communique has been published by the BMJ

    The primary aim of this study was to explore whether subscribers reported clinical practice changes as a result of reading the CC. It also compared the characteristics of subscribers who self-reported changes to clinical practice with those who did not, and explores subscribers’ perceptions of the educational value of the CC.

  • Background infusions with PCA can be unsafe – but are concurrent oral opioids any safer?

    Background infusions with PCA can be unsafe – but are concurrent oral opioids any safer?

    Following the discussion on patient-controlled-analgesia (PCA) in our June issue of the Clinical Communiqué, we present a supplementary expert commentary with pertinent clinical advice for our readers on the use of oral opioids with PCAs.

ARCHIVE